Consolidated Cash Flow Statement
For the year ended 31 December | |||
---|---|---|---|
Note | 2015 HK$ million |
2014 HK$ million |
|
Cash flows from operating activities | |||
Profit before taxation | 81,306 | 77,800 | |
Adjustments for: | |||
– Depreciation and amortisation | 10(b) | 12,038 | 9,977 |
– Impairment losses | 8 | 79,004 | 55,020 |
– Net valuation gain on investment properties | 32 | (661) | (2,332) |
– Net valuation gain on investments | (668) | (535) | |
– Share of profits of associates and joint ventures, net of tax | (4,667) | (7,714) | |
– Interest expenses on debts instruments issued | 5(a) | 10,439 | 5,825 |
– Finance income | 9 | (2,794) | (2,250) |
– Finance costs | 9 | 11,024 | 11,054 |
– Net (gain)/loss on available-for-sale financial assets | (11,884) | 57 | |
– Net gain on disposal of subsidiaries, associates and joint ventures | (13,795) | (2,556) | |
159,342 | 144,346 | ||
Changes in working capital | |||
Decrease/(increase) in deposits with central banks, banks and non-bank financial institutions | 4,676 | (5,196) | |
(Increase)/decrease in placements with banks and non-bank financial institutions | (42,833) | 90,962 | |
Increase in financial assets at fair value through profit or loss and derivative financial assets | (9,058) | (27,791) | |
Decrease in trade and other receivables | (11,015) | (32,627) | |
(Increase)/decrease in amounts due from customers for contract work | (787) | 296 | |
Decrease in inventories | 2,407 | 2,068 | |
(Increase)/decrease in financial assets held under resale agreements | (3,433) | 191,182 | |
Increase in loans and advances to customers and other parties | (446,580) | (300,177) | |
Increase in investments classified as receivables | (575,313) | (452,794) | |
Increase in other assets | (10,846) | (38,802) | |
Increase in deposits from banks and non-bank financial institutions | 472,768 | 168,642 | |
Increase/(decrease) in placements from banks and non-bank financial institutions | 36,554 | (28,047) | |
(Decrease)/increase in financial liabilities at fair value through profit or loss and derivative financial liabilities | (714) | 724 | |
Increase/(decrease) in trade and other payables | 33,582 | (8,397) | |
(Decrease)/increase in amounts due to customers for contract work | (3,422) | 2,641 | |
Increase in financial assets sold under repurchase agreements | 36,802 | 42,477 | |
Increase in deposits from customers | 388,622 | 249,318 | |
(Decrease)/increase in borrowing from central banks | (15,630) | 63,167 | |
Increase in other liabilities | 9,254 | 9,923 | |
(Decrease)/increase in employee benefits payables | (2,689) | 2,525 | |
Increase in provisions | 711 | 270 | |
Cash generated from operations | 22,398 | 74,710 | |
Income tax paid | (22,089) | (15,773) | |
Net cash generated from operating activities | 309 | 58,937 | |
Cash flows from investing activities | |||
Proceeds from disposal and redemption of financial investments | 887,424 | 564,404 | |
Proceeds from disposal of fixed assets, intangible assets and other assets | 197 | 665 | |
Proceeds from disposal of associates and joint ventures | 14,312 | 1,031 | |
Net cash received from disposal of subsidiaries | 51(b) | 2,926 | 3,744 |
Dividends received from equity investments, associates and joint ventures | 6,158 | 5,715 | |
Payments for purchase of financial investments | (1,021,956) | (653,689) | |
Payments for additions of fixed assets, intangible assets and other assets | (24,388) | (24,217) | |
Net cash payment for acquisition of subsidiaries, associates and joint ventures | (8,201) | (2,702) | |
Acquisition of non-controlling interests | - | (2,542) | |
Net cash used in investing activities | (143,528) | (107,591) | |
Cash flows from financing activities | |||
Capital injection received from the controlling shareholder | - | 21,455 | |
Capital injection received from non-controlling interests | 566 | 418 | |
Transaction with non-controlling interests | 52 | 7,363 | - |
Capital injection received from the shareholders of the Company | 57,909 | 53,274 | |
Net cash payment for acquisition of subsidiaries, associates, and joint ventures | - | (53,357) | |
Proceeds from new bank and other loans | 107,991 | 134,981 | |
Repayment of bank and other loans and debt instruments issued | (372,928) | (180,174) | |
Proceeds from new debt instruments issued | 398,192 | 129,766 | |
Proceeds from other equity instruments issued | 1,363 | 2,303 | |
Interest paid on bank and other loans and debt instruments issued | (26,874) | (19,286) | |
Dividends paid to non-controlling interests | (2,073) | (5,987) | |
Dividends paid to ordinary shareholders of the Company | 14 | (7,890) | (22,741) |
Distribution paid to holders of perpetual capital securities | (1,133) | (1,134) | |
Net cash generated from financing activities | 162,486 | 59,518 | |
Net increase in cash and cash equivalents | 19,267 | 10,864 | |
Cash and cash equivalents at 1 January | 347,891 | 337,894 | |
Effect of exchange changes | (13,047) | (867) | |
Cash and cash equivalents at 31 December | 51(a) | 354,111 | 347,891 |
The notes on pages 171 to 314 form part of these consolidated financial statements.